By the Top Tier Newswire AI Desk · November 13, 2026 at 10:00 AM ET · reviewed against 5 wire stories
ALVOTECH (ALVO) is down -7.28% in the latest session. Our newswire has captured 5 stories on ALVO across 4 sources in the last 36 hours, with AI sentiment reading mixed (avg 56/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Alvotech (ALVO) shares fell 7.28% to $4.33 following the release of its third-quarter financial results. The decline was driven by a quarterly earnings miss and guidance that points toward the lower end of the company’s full-year revenue outlook.
What Happened
Alvotech reported third-quarter revenue of $111.6 million, which missed the $119.037 million estimate. The company also posted an earnings per share of $(0.23), falling short of the $(0.07) expectation. Adjusted EBITDA rose to $78.3 million. Management affirmed its full-year 2026 guidance of $650 million to $700 million in revenue and $180 million to $220 million in adjusted EBITDA. However, the company expects 2026 results to trend toward the low end of this range. The earnings call highlighted a manufacturing recovery that drove a sharp quarterly rebound, though targets remain conservative.
What The Data Shows
The stock opened at $4.54, a 2.8% gap down from the prior close of $4.67. It reached a session high of $4.63 at 9:30 AM ET before hitting a session low of $4.31 at 9:55 AM ET. Volume stood at 0.2 million shares, which is 0.2 times the three-month daily average. The company has a market capitalization of $1.8 billion and remains unprofitable with a trailing twelve-month EPS of -0.81. Revenue has declined 14.1% over the trailing twelve months, and the net margin is -50.6%. The stock has a beta of 0.24 and a 52-week range of $2.94 to $6.53. Over the last eight sessions, the stock had moved up 2.9% from $4.54 to $4.67. The stock printed six fresh 52-week lows on November 13, 2026.
What To Watch
Investors will monitor how the company executes its manufacturing recovery and whether revenue trends toward the low end of the $650 million to $700 million guidance range. The coverage breadth remains active with multiple stories published in the last 36 hours.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
ALVO · today's session (5-min) · -10.28% vs prior close · updated 8:08 PM ETAI sentiment, last 36h · averaged over 5 stories · 56/100 bullish
The headlines behind the move
Story flow · 4 stories on the wire, last 36h · hover or tap a dot for the headline
1d agoTipRanksBULLISH 63Earnings
Alvotech Earnings Call Highlights Growth and Risks
Alvotech (($ALVO)) has held its Q3 earnings call. Read on for the main highlights of the call. Alvotech’s earnings call struck a predominantly positive tone, led by...
1d agoSeeking AlphaBULLISH 74Earnings
Alvotech targets $650M-$700M revenue and $180M-$220M EBITDA as it expects Q4 to be “the strongest” in company history
Alvotech expects 2026 results to trend toward the low end of guidance: revenue of $650 million-$700 million and adjusted EBITDA of $180 million-$220...
1d agoSeeking AlphaBEARISH 34Earnings
Alvotech falls on Q3 results
Alvotech misses Q3 earnings and expects revenue at the lower end of its $650M-$700M full-year outlook; adjusted EBITDA rises to $78.3M. Read more here.
1d agoThe Motley FoolBULLISH 58Earnings
Alvotech (ALVO) Q3 2026 Earnings Call Transcript
Manufacturing recovery drove a sharp quarterly rebound, but targets point to the low end.
2d agoGlobeNewswireNEUTRAL 50Earnings
Alvotech Announces Financial Results for the Nine Months to September 30, 2026, with a Business Update
REYKJAVIK, Iceland, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →